The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression
- PMID: 19385599
- PMCID: PMC2757002
- DOI: 10.1021/jm900055s
The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression
Abstract
The importance of DNA supercoiling in transcriptional regulation has been known for many years, and more recently, transcription itself has been shown to be a source of this superhelicity. To mimic the effect of transcriptionally induced negative superhelicity, the G-quadruplex/i-motif-forming region in the c-Myc promoter was incorporated into a supercoiled plasmid. We show, using enzymatic and chemical footprinting, that negative superhelicity facilitates the formation of secondary DNA structures under physiological conditions. Significantly, these structures are not the same as those formed in single-stranded DNA templates. Together with the recently demonstrated role of transcriptionally induced superhelicity in maintaining a mechanosensor mechanism for controlling the firing rate of the c-Myc promoter, we provide a more complete picture of how c-Myc transcription is likely controlled. Last, these physiologically relevant G-quadruplex and i-motif structures, along with the mechanosensor mechanism for control of gene expression, are proposed as novel mechanisms for small molecule targeting of transcriptional control of c-Myc.
Figures
References
-
- Marcu KB. Regulation of expression of the c-myc proto-oncogene. Bioessays. 1987;6:28–32. - PubMed
-
- Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 2002;109:321–334. - PubMed
-
- Pelengaris S, Khan M. The c-Myc oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin. Ther. Targets. 2003;7:623–642. - PubMed
-
- Spencer CA, Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 1991;56:1–48. - PubMed
-
- Marcu KB, Patel AJ, Yang Y. Differential regulation of the c-Myc P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated Myc transcription. Curr. Top. Microbiol. Immunol. 1997;224:47–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
